ReviewPharmaceutics2024

Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer.

Ryunosuke Hoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.